Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis
- 15 June 2012
- journal article
- Published by Wiley in Liver International
- Vol. 32 (9) , 1342-1353
Abstract
Background and Aims: CCN3/NOV, a matricellular protein of the CYR61‐CTGF‐NOV (CCN) family, comprises six secreted proteins that associate specifically with the extracellular matrix. CCN proteins lack specific high‐affinity receptors; instead, they regulate crucial biological processes, such as fibrosis, by signalling via integrins and proteoglycans. Recent studies have linked overexpression of CCN3/NOV to mitigate kidney fibrosis. This study aims to investigate CCN3/NOV overexpression in liver fibrogenesis in vivo.Methods: The biological efficacy of adenoviral expressed CCN3/NOV directed under transcriptional control of the constitutively active Cytomegalovirus promoter (Ad‐NOV) was analysed in a bile duct ligation model and in cultured primary hepatocytes.Results and Conclusions: Even though Ad‐NOV gene transfer in a 3‐week bile duct ligation mouse model showed the expected high levels of CCN3/NOV in both mRNA and protein, it failed to reduce liver fibrogenesis, but instead enhanced hepatocyte apoptosis. Furthermore, overexpressed CCN3/NOV in cultured primary hepatocytes resulted in decreased levels of CCN2/CTGF, the profibrotic marker protein in liver fibrosis. Both Ad‐NOV and Ad‐CTGF induced reactive oxygen species production, enhanced p38 and JNK activation. Therefore, we conclude that CCN3/NOV overexpression in vivo is insufficient to mitigate liver fibrogenesis because of the induction of hepatocyte injury and apoptosis.Keywords
This publication has 41 references indexed in Scilit:
- CCN proteins in normal and injured liverFrontiers in Bioscience-Landmark, 2011
- Evolving challenges in hepatic fibrosisNature Reviews Gastroenterology & Hepatology, 2010
- CCN3/CCN2 regulation and the fibrosis of diabetic renal diseaseJournal of Cell Communication and Signaling, 2010
- CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal DiseaseThe American Journal of Pathology, 2009
- Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF‐β as major players and therapeutic targetsJournal of Cellular and Molecular Medicine, 2006
- Nephroblastoma overexpressed gene (NOV) expression in rat hepatic stellate cellsBiochemical Pharmacology, 2004
- Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-βNature Cell Biology, 2002
- Role and interaction of connective tissue growth factor with transforming growth factor-? in persistent fibrosis: A mouse fibrosis modelJournal of Cellular Physiology, 1999
- The CCN Family of Angiogenic Regulators: The Integrin ConnectionExperimental Cell Research, 1999
- The modular architecture of a new family of growth regulators related to connective tissue growth factorFEBS Letters, 1993